Abstract: A base material is made of a flexible resin, and formed in the shape of a sheet provided with a hollow portion. The base material can be wrapped around, for example, a forearm, an upper arm, a wrist, or the like. A sweat absorption unit is made of a plurality of fibers, and is arranged at the hollow portion for taking up sweat that has been taken in by a suction port. The sweat absorption unit is made of, for example, paper made of cellulose. A sodium ion detection electrode, a potassium ion detection electrode, and a reference electrode are allowed to contact the sweat that has been suctioned from the suction port of the sweat absorption unit and taken up into the sweat absorption unit, to detect ions contained in the sweat.

Abstract: The present invention provides novel angiogenesis inhibitors effective, safe and highly practical for inhibition of angiogenesis in various diseases, and a method for screening the same. The active ingredients of the angiogenesis inhibitors of the present invention comprise ansamycin antibiotics such as rifampicin, rifamycin SV and 3-formyl rifamycin, which have long been used extensively as antibacterial agents for treating tuberculosis or Gram-positive bacterial infections. The active ingredients of the present invention have excellent angiogenesis-inhibiting activity. The angiogenesis inhibitor of the present invention is effective for inhibition of angiogenesis in malignant tumors, diabetic retinopathy, retinal angiogenesis, inflammatory diseases, and angiogenesis accompanying cardiovascular remodeling, etc., and can be used as therapeutic agents against each disease, etc.

Abstract: The present invention provides novel angiogenesis inhibitors effective, safe and highly practical for inhibition of angiogenesis in various diseases, and a method for screening the same. The active ingredients of the angiogenesis inhibitors of the present invention comprise ansamycin antibiotics such as rifampicin, rifamycin SV and 3-formyl rifamycin, which have long been used extensively as antibacterial agents for treating tuberculosis or Gram-positive bacterial infections. The active ingredients of the present invention have excellent angiogenesis-inhibiting activity. The angiogenesis inhibitor of the present invention is effective for inhibition of angiogenesis in malignant tumors, diabetic retinopathy, retinal angiogenesis, inflammatory diseases, and angiogenesis accompanying cardiovascular remodeling, etc., and can be used as therapeutic agents against each disease, etc.

Abstract: The present invention provides novel angiogenesis inhibitors effective, safe and highly practical for inhibition of angiogenesis in various diseases, and a method for screening the same. The active ingredients of the angiogenesis inhibitors of the present invention comprise ansamycin antibiotics such as rifampicin, rifamycin SV and 3-formyl rifamycin, which have long been used extensively as antibacterial agents for treating tuberculosis or Gram-positive bacterial infections. The active ingredients of the present invention have excellent angiogenesis-inhibiting activity. The angiogenesis inhibitor of the present invention is effective for inhibition of angiogenesis in malignant tumors, diabetic retinopathy, retinal angiogenesis, inflammatory diseases, and angiogenesis accompanying cardiovascular remodeling, etc., and can be used as therapeutic agents against each disease, etc.

Abstract: A cable take-up device mounted at the rear of an electric drive vehicle for winding and unwinding a feeder cable. The device controls a winding angle of the take-up cable so as to maintan it constant. A slack angle of the cable is an angle made between a line drawn along the cable in the vicinity of a winding point and a plane including the winding point and being perpendicular to an absolute plane. According to the invention, this slack angle is controlled so as to provide an optimum tension constantly regardless of forward or reverse running speed change or steering of the vehicle.